In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Glaxo acquires Wellcome in $14 billion hostile bid

Executive Summary

In a surprise takeover offer, Glaxo has offered Wellcome shareholders $14.15 billion, or $16.20 (UK10.25) per share or ADS (a 49% premium to Wellcome's recent closing price of about $10.75) in cash and stock. Update: deal finalized.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition

Related Companies